Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2019
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study | 01/04/2019 | INTERVENTIONAL | unchanged | 2,791.85 | 0 |
|---|
| Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization | 01/07/2019 | OBSERVATIONAL | unchanged | 2,788.85 | 0 |
|---|
| Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer | 01/07/2019 | INTERVENTIONAL | unchanged | 2,788.85 | 0 |
|---|
| Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer | 01/08/2019 | INTERVENTIONAL | unchanged | 2,787.85 | 0 |
|---|
| A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer | 01/09/2019 | OBSERVATIONAL | unchanged | 2,786.85 | 0 |
|---|
| Converting HR+ Breast Cancer Into an Individualized Vaccine | 01/15/2019 | INTERVENTIONAL | unchanged | 2,780.85 | 0 |
|---|
| Mechanisms of Pregnancy Vascular Adaptations | 01/16/2019 | OBSERVATIONAL | unchanged | 2,779.85 | 0 |
|---|
| Cognitive Training for Patients With Eating Disorders | 01/17/2019 | INTERVENTIONAL | unchanged | 2,778.85 | 0 |
|---|
| Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | 01/24/2019 | INTERVENTIONAL | unchanged | 2,771.85 | 0 |
|---|
| Elevate! : An Elderly Breast Cancer Cohort Study | 01/28/2019 | OBSERVATIONAL | unchanged | 2,767.85 | 0 |
|---|
| Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections | 01/28/2019 | INTERVENTIONAL | unchanged | 2,767.85 | 0 |
|---|
| Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer | 01/29/2019 | INTERVENTIONAL | unchanged | 2,766.85 | 0 |
|---|
| Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair | 01/29/2019 | INTERVENTIONAL | unchanged | 2,766.85 | 0 |
|---|
| Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease | 01/30/2019 | INTERVENTIONAL | unchanged | 2,765.85 | 0 |
|---|
| A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy | 01/30/2019 | INTERVENTIONAL | unchanged | 2,765.85 | 0 |
|---|
| Bioimpedance In Pregnancy and Labour: A Fluid Balance Concept Study. | 01/31/2019 | OBSERVATIONAL | unchanged | 2,764.85 | 0 |
|---|
| Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer | 01/31/2019 | INTERVENTIONAL | unchanged | 2,764.85 | 0 |
|---|
| HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer | 02/01/2019 | INTERVENTIONAL | unchanged | 2,763.85 | 0 |
|---|
| Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II | 02/04/2019 | INTERVENTIONAL | unchanged | 2,760.85 | 0 |
|---|
| Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment | 02/04/2019 | INTERVENTIONAL | unchanged | 2,760.85 | 0 |
|---|
| Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting | 02/05/2019 | INTERVENTIONAL | unchanged | 2,759.85 | 0 |
|---|
| PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood | 02/05/2019 | INTERVENTIONAL | unchanged | 2,759.85 | 0 |
|---|
| Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer | 02/06/2019 | INTERVENTIONAL | unchanged | 2,758.85 | 0 |
|---|
| TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation | 02/07/2019 | INTERVENTIONAL | unchanged | 2,757.85 | 0 |
|---|
| A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | 02/11/2019 | INTERVENTIONAL | unchanged | 2,753.85 | 0 |
|---|
| Body Fat as Determinant of Female Gonadal Dysfunction | 02/15/2019 | OBSERVATIONAL | unchanged | 2,749.85 | 0 |
|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) | 02/15/2019 | INTERVENTIONAL | unchanged | 2,749.85 | 0 |
|---|
| Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease | 02/22/2019 | INTERVENTIONAL | unchanged | 2,742.85 | 0 |
|---|
| FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II) | 02/26/2019 | INTERVENTIONAL | unchanged | 2,738.85 | 0 |
|---|
| A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine | 02/26/2019 | INTERVENTIONAL | unchanged | 2,738.85 | 0 |
|---|
| Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele | 02/27/2019 | INTERVENTIONAL | unchanged | 2,737.85 | 0 |
|---|
| Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer | 02/27/2019 | INTERVENTIONAL | unchanged | 2,737.85 | 0 |
|---|
| Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET | 03/01/2019 | INTERVENTIONAL | unchanged | 2,735.85 | 0 |
|---|
| SALpingectomy for STERilization (SALSTER) | 03/04/2019 | INTERVENTIONAL | unchanged | 2,732.85 | 0 |
|---|
| Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening | 03/05/2019 | INTERVENTIONAL | unchanged | 2,731.85 | 0 |
|---|
| Determining Prognostic Immune Markers in Patients With Ovarian Cancer | 03/05/2019 | OBSERVATIONAL | unchanged | 2,731.85 | 0 |
|---|
| Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease | 03/07/2019 | INTERVENTIONAL | unchanged | 2,729.85 | 0 |
|---|
| Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients | 03/12/2019 | INTERVENTIONAL | unchanged | 2,724.85 | 0 |
|---|
| Best Start - Weight Management During Pregnancy | 03/14/2019 | INTERVENTIONAL | unchanged | 2,722.85 | 0 |
|---|
| Transdermal Estrogen in Women With Anorexia Nervosa | 03/14/2019 | INTERVENTIONAL | unchanged | 2,722.85 | 0 |
|---|
| Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: | 03/14/2019 | INTERVENTIONAL | unchanged | 2,722.85 | 0 |
|---|
| Vaginal Native Tissues Repair for Pelvic Organ Prolapse | 03/15/2019 | INTERVENTIONAL | unchanged | 2,721.85 | 0 |
|---|
| Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB) | 03/15/2019 | INTERVENTIONAL | unchanged | 2,721.85 | 0 |
|---|
| Clinical Pre-screening Protocol for Ovarian Cancer | 03/18/2019 | OBSERVATIONAL | unchanged | 2,718.85 | 0 |
|---|
| Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast | 03/18/2019 | INTERVENTIONAL | unchanged | 2,718.85 | 0 |
|---|
| Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer | 03/18/2019 | INTERVENTIONAL | unchanged | 2,718.85 | 0 |
|---|
| Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | 03/19/2019 | INTERVENTIONAL | unchanged | 2,717.85 | 0 |
|---|
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma | 03/19/2019 | INTERVENTIONAL | unchanged | 2,717.85 | 0 |
|---|
| Sub-type Specific Genomic Mutations in sBOTs | 03/21/2019 | OBSERVATIONAL | unchanged | 2,715.85 | 0 |
|---|
| Attitudes and Decision-making After Pregnancy Testing Study | 03/25/2019 | OBSERVATIONAL | unchanged | 2,711.85 | 0 |
|---|
| Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer | 03/27/2019 | OBSERVATIONAL | unchanged | 2,709.85 | 0 |
|---|
| Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy | 03/27/2019 | INTERVENTIONAL | unchanged | 2,709.85 | 0 |
|---|
| Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry) | 03/28/2019 | OBSERVATIONAL | unchanged | 2,708.85 | 0 |
|---|
| Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects | 04/01/2019 | INTERVENTIONAL | unchanged | 2,704.85 | 0 |
|---|
| PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate | 04/03/2019 | INTERVENTIONAL | unchanged | 2,702.85 | 0 |
|---|
| Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure | 04/03/2019 | INTERVENTIONAL | unchanged | 2,702.85 | 0 |
|---|
| Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer | 04/03/2019 | INTERVENTIONAL | unchanged | 2,702.85 | 0 |
|---|
| Effect of Prednisolone Treatment on Uterine Natural Killer Cells | 04/04/2019 | INTERVENTIONAL | unchanged | 2,701.85 | 0 |
|---|
| Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer | 04/09/2019 | INTERVENTIONAL | unchanged | 2,696.85 | 0 |
|---|
| Oxytocin Receptor Expression in Pregnancy | 04/09/2019 | OBSERVATIONAL | unchanged | 2,696.85 | 0 |
|---|
| Fit-for-Fertility Multicenter Randomized Controlled Trial | 04/09/2019 | INTERVENTIONAL | unchanged | 2,696.85 | 0 |
|---|
| Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma | 04/10/2019 | INTERVENTIONAL | unchanged | 2,695.85 | 0 |
|---|
| DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome | 04/11/2019 | OBSERVATIONAL | unchanged | 2,694.85 | 0 |
|---|
| Study of Treatment for HPV16+ ASC-US or LSIL | 04/12/2019 | INTERVENTIONAL | unchanged | 2,693.85 | 0 |
|---|
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer | 04/16/2019 | INTERVENTIONAL | unchanged | 2,689.85 | 0 |
|---|
| The Pregnancy & Early Life Study | 04/16/2019 | OBSERVATIONAL | unchanged | 2,689.85 | 0 |
|---|
| Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women | 04/16/2019 | INTERVENTIONAL | unchanged | 2,689.85 | 0 |
|---|
| Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | 04/16/2019 | INTERVENTIONAL | unchanged | 2,689.85 | 0 |
|---|
| Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast Cancer | 04/17/2019 | INTERVENTIONAL | unchanged | 2,688.85 | 0 |
|---|
| Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes | 04/22/2019 | OBSERVATIONAL | unchanged | 2,683.85 | 0 |
|---|
| Transcriptome Profiling and Endometrial Receptivity | 04/24/2019 | OBSERVATIONAL | unchanged | 2,681.85 | 0 |
|---|
| Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection | 04/25/2019 | INTERVENTIONAL | unchanged | 2,680.85 | 0 |
|---|
| Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP) | 04/25/2019 | OBSERVATIONAL | unchanged | 2,680.85 | 0 |
|---|
| Consequences of Unwanted Pregnancy in Nepal | 04/29/2019 | OBSERVATIONAL | unchanged | 2,676.85 | 0 |
|---|
| Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer | 04/30/2019 | INTERVENTIONAL | unchanged | 2,675.85 | 0 |
|---|
| An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) | 05/03/2019 | OBSERVATIONAL | unchanged | 2,672.85 | 0 |
|---|
| Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer | 05/03/2019 | INTERVENTIONAL | unchanged | 2,672.85 | 0 |
|---|
| Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders | 05/06/2019 | INTERVENTIONAL | unchanged | 2,669.85 | 0 |
|---|
| Women's Advanced Risk-assessment in Manitoba | 05/06/2019 | OBSERVATIONAL | unchanged | 2,669.85 | 0 |
|---|
| Usability Study of the Sensors and eMOM GDM Application | 05/08/2019 | OBSERVATIONAL | unchanged | 2,667.85 | 0 |
|---|
| Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer | 05/08/2019 | INTERVENTIONAL | unchanged | 2,667.85 | 0 |
|---|
| Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery | 05/09/2019 | INTERVENTIONAL | unchanged | 2,666.85 | 0 |
|---|
| Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies | 05/09/2019 | OBSERVATIONAL | unchanged | 2,666.85 | 0 |
|---|
| Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy | 05/14/2019 | INTERVENTIONAL | unchanged | 2,661.85 | 0 |
|---|
| Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer | 05/14/2019 | INTERVENTIONAL | unchanged | 2,661.85 | 0 |
|---|
| The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study | 05/14/2019 | OBSERVATIONAL | unchanged | 2,661.85 | 0 |
|---|
| Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women | 05/15/2019 | INTERVENTIONAL | unchanged | 2,660.85 | 0 |
|---|
| Platino-resistance in Ovarian Cancer | 05/17/2019 | INTERVENTIONAL | unchanged | 2,658.85 | 0 |
|---|
| High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT) | 05/17/2019 | INTERVENTIONAL | unchanged | 2,658.85 | 0 |
|---|
| Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer | 05/20/2019 | INTERVENTIONAL | unchanged | 2,655.85 | 0 |
|---|
| TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer | 05/20/2019 | INTERVENTIONAL | unchanged | 2,655.85 | 0 |
|---|
| Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence | 05/21/2019 | INTERVENTIONAL | unchanged | 2,654.85 | 0 |
|---|
| Clinico-biological Data Collection Study of Metastatic Breast Cancer | 05/21/2019 | INTERVENTIONAL | unchanged | 2,654.85 | 0 |
|---|
| AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) | 05/22/2019 | INTERVENTIONAL | unchanged | 2,653.85 | 0 |
|---|
| Cancer Activity and Lifestyle Measurement Study | 05/23/2019 | OBSERVATIONAL | unchanged | 2,652.85 | 0 |
|---|
| Quality of Life, Aesthetic Result and Health Economy in Breast Reconstruction | 05/24/2019 | INTERVENTIONAL | unchanged | 2,651.85 | 0 |
|---|
| PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer | 05/29/2019 | INTERVENTIONAL | unchanged | 2,646.85 | 0 |
|---|
| A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer | 05/31/2019 | OBSERVATIONAL | unchanged | 2,644.85 | 0 |
|---|
| EASE: The Materna Prep Pivotal Study | 06/04/2019 | INTERVENTIONAL | unchanged | 2,640.85 | 0 |
|---|
| Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation | 06/05/2019 | INTERVENTIONAL | unchanged | 2,639.85 | 0 |
|---|
| Three Fraction Radiation to Induce Immuno-Oncologic Response | 06/07/2019 | INTERVENTIONAL | unchanged | 2,637.85 | 0 |
|---|
| A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer | 06/10/2019 | INTERVENTIONAL | unchanged | 2,634.85 | 0 |
|---|
| Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH | 06/10/2019 | INTERVENTIONAL | unchanged | 2,634.85 | 0 |
|---|
| ANgiogenic Function at NOrmal TErm on Placenta | 06/11/2019 | OBSERVATIONAL | unchanged | 2,633.85 | 0 |
|---|
| A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer | 06/11/2019 | INTERVENTIONAL | unchanged | 2,633.85 | 0 |
|---|
| Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer | 06/11/2019 | INTERVENTIONAL | unchanged | 2,633.85 | 0 |
|---|
| Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) | 06/12/2019 | INTERVENTIONAL | unchanged | 2,632.85 | 0 |
|---|
| A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients | 06/12/2019 | OBSERVATIONAL | unchanged | 2,632.85 | 0 |
|---|
| Sexual Health Empowerment for Women's Health | 06/13/2019 | INTERVENTIONAL | unchanged | 2,631.85 | 0 |
|---|
| Reproductive Axis Maturation in the Early Post-Menarchal Years | 06/14/2019 | OBSERVATIONAL | unchanged | 2,630.85 | 0 |
|---|
| Exercise Treatment With Standard Therapy for Metastatic Breast Cancer | 06/17/2019 | INTERVENTIONAL | unchanged | 2,627.85 | 0 |
|---|
| Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation | 06/18/2019 | INTERVENTIONAL | unchanged | 2,626.85 | 0 |
|---|
| Primary Ovarian Insufficient Patients | 06/18/2019 | OBSERVATIONAL | unchanged | 2,626.85 | 0 |
|---|
| Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial | 06/19/2019 | INTERVENTIONAL | unchanged | 2,625.85 | 0 |
|---|
| PCOS (Polycystic Ovarian Syndrome) Patients | 06/19/2019 | OBSERVATIONAL | unchanged | 2,625.85 | 0 |
|---|
| Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab | 06/20/2019 | OBSERVATIONAL | unchanged | 2,624.85 | 0 |
|---|
| Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey | 06/21/2019 | INTERVENTIONAL | unchanged | 2,623.85 | 0 |
|---|
| Palliative Radiation for Advanced Cervical Cancer | 06/25/2019 | INTERVENTIONAL | unchanged | 2,619.85 | 0 |
|---|
| Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) | 06/26/2019 | INTERVENTIONAL | unchanged | 2,618.85 | 0 |
|---|
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer | 06/28/2019 | INTERVENTIONAL | unchanged | 2,616.85 | 0 |
|---|
| Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery | 07/01/2019 | INTERVENTIONAL | unchanged | 2,613.85 | 0 |
|---|
| Hepcidin and Glucose Metabolism | 07/05/2019 | INTERVENTIONAL | unchanged | 2,609.85 | 0 |
|---|
| Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium | 07/05/2019 | INTERVENTIONAL | unchanged | 2,609.85 | 0 |
|---|
| Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast | 07/05/2019 | INTERVENTIONAL | unchanged | 2,609.85 | 0 |
|---|
| Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour | 07/08/2019 | INTERVENTIONAL | unchanged | 2,606.85 | 0 |
|---|
| Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain | 07/08/2019 | INTERVENTIONAL | unchanged | 2,606.85 | 0 |
|---|
| Arm and Finger Measurement for Blood Pressure Surveillance | 07/09/2019 | OBSERVATIONAL | unchanged | 2,605.85 | 0 |
|---|
| Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women | 07/10/2019 | OBSERVATIONAL | unchanged | 2,604.85 | 0 |
|---|
| Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy | 07/10/2019 | OBSERVATIONAL | unchanged | 2,604.85 | 0 |
|---|
| FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery | 07/11/2019 | INTERVENTIONAL | unchanged | 2,603.85 | 0 |
|---|
| Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. | 07/15/2019 | INTERVENTIONAL | unchanged | 2,599.85 | 0 |
|---|
| Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients | 07/17/2019 | OBSERVATIONAL | unchanged | 2,597.85 | 0 |
|---|
| NeoVax With Nivolumab in Patients With Ovarian Cancer | 07/18/2019 | INTERVENTIONAL | unchanged | 2,596.85 | 0 |
|---|
| Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery | 07/18/2019 | INTERVENTIONAL | unchanged | 2,596.85 | 0 |
|---|
| Deceased Uterine Transplant in Absolute Uterine Infertility (AUIF) | 07/19/2019 | INTERVENTIONAL | unchanged | 2,595.85 | 0 |
|---|
| Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients | 07/24/2019 | INTERVENTIONAL | unchanged | 2,590.85 | 0 |
|---|
| Transcriptional and Epigenetic Program of PCOS Women | 07/26/2019 | OBSERVATIONAL | unchanged | 2,588.85 | 0 |
|---|
| Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer | 07/29/2019 | INTERVENTIONAL | unchanged | 2,585.85 | 0 |
|---|
| Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. | 07/31/2019 | INTERVENTIONAL | unchanged | 2,583.85 | 0 |
|---|
| A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer | 07/31/2019 | INTERVENTIONAL | unchanged | 2,583.85 | 0 |
|---|
| Laser Vaginal Treatment for GSM | 08/02/2019 | INTERVENTIONAL | unchanged | 2,581.85 | 0 |
|---|
| Bioenergetic Effects of Aging and Menopause (BEAM) | 08/02/2019 | INTERVENTIONAL | unchanged | 2,581.85 | 0 |
|---|
| LASER and Radiofrequency and Genitourinary Syndrome of Menopause | 08/05/2019 | INTERVENTIONAL | unchanged | 2,578.85 | 0 |
|---|
| Vaginal Microbiota Transplant | 08/06/2019 | INTERVENTIONAL | unchanged | 2,577.85 | 0 |
|---|
| Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA | 08/07/2019 | INTERVENTIONAL | unchanged | 2,576.85 | 0 |
|---|
| Perioperative Mindfulness Proposal | 08/08/2019 | INTERVENTIONAL | unchanged | 2,575.85 | 0 |
|---|
| IDENTIFY Study: Natural History of Maternal Neoplasia | 08/08/2019 | INTERVENTIONAL | unchanged | 2,575.85 | 0 |
|---|
| Improving Cognition After Cancer | 08/08/2019 | INTERVENTIONAL | unchanged | 2,575.85 | 0 |
|---|
| Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer | 08/08/2019 | INTERVENTIONAL | unchanged | 2,575.85 | 0 |
|---|
| Autonomic Determinants of POTS - Pilot1 | 08/08/2019 | INTERVENTIONAL | unchanged | 2,575.85 | 0 |
|---|
| DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast | 08/12/2019 | INTERVENTIONAL | unchanged | 2,571.85 | 0 |
|---|
| Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study | 08/12/2019 | INTERVENTIONAL | unchanged | 2,571.85 | 0 |
|---|
| Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC | 08/13/2019 | INTERVENTIONAL | unchanged | 2,570.85 | 0 |
|---|
| ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer | 08/14/2019 | INTERVENTIONAL | unchanged | 2,569.85 | 0 |
|---|
| Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN | 08/15/2019 | OBSERVATIONAL | unchanged | 2,568.85 | 0 |
|---|
| Westlake Precision Birth Cohort | 08/16/2019 | INTERVENTIONAL | unchanged | 2,567.85 | 0 |
|---|
| Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. | 08/20/2019 | INTERVENTIONAL | unchanged | 2,563.85 | 0 |
|---|
| Phase III Trial of Stage I Ovarian Cancer After Surgery | 08/21/2019 | INTERVENTIONAL | unchanged | 2,562.85 | 0 |
|---|
| GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET | 08/22/2019 | INTERVENTIONAL | unchanged | 2,561.85 | 0 |
|---|
| The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer | 08/22/2019 | INTERVENTIONAL | unchanged | 2,561.85 | 0 |
|---|
| ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | 08/22/2019 | INTERVENTIONAL | unchanged | 2,561.85 | 0 |
|---|
| Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer | 08/22/2019 | OBSERVATIONAL | unchanged | 2,561.85 | 0 |
|---|
| RANKL Inhibition and Mammographic Breast Density | 08/26/2019 | INTERVENTIONAL | unchanged | 2,557.85 | 0 |
|---|
| Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients | 08/28/2019 | OBSERVATIONAL | unchanged | 2,555.85 | 0 |
|---|
| Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer | 08/28/2019 | INTERVENTIONAL | unchanged | 2,555.85 | 0 |
|---|
| Implementation of Prevention and Intervention of Maternal Perinatal Depression to Strengthen Maternal and Child Health | 08/28/2019 | INTERVENTIONAL | unchanged | 2,555.85 | 0 |
|---|
| RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer | 08/28/2019 | INTERVENTIONAL | unchanged | 2,555.85 | 0 |
|---|
| Sentinel Node Biopsy Vs Observation After Axillary PET | 08/28/2019 | INTERVENTIONAL | unchanged | 2,555.85 | 0 |
|---|
| Sentinel Node Biopsy in Endometrial Cancer | 08/29/2019 | INTERVENTIONAL | unchanged | 2,554.85 | 0 |
|---|
| Early PrEgnancy Complications Testing | 09/06/2019 | INTERVENTIONAL | unchanged | 2,546.85 | 0 |
|---|
| LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) | 09/09/2019 | INTERVENTIONAL | unchanged | 2,543.85 | 0 |
|---|
| Uptake of Genetic Counseling Among African American Women | 09/09/2019 | INTERVENTIONAL | unchanged | 2,543.85 | 0 |
|---|
| Induction of Gut Permeability by an Oral Vaccine | 09/10/2019 | INTERVENTIONAL | unchanged | 2,542.85 | 0 |
|---|
| Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer | 09/10/2019 | INTERVENTIONAL | unchanged | 2,542.85 | 0 |
|---|
| Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer | 09/10/2019 | INTERVENTIONAL | unchanged | 2,542.85 | 0 |
|---|
| Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia | 09/10/2019 | INTERVENTIONAL | unchanged | 2,542.85 | 0 |
|---|
| Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania | 09/11/2019 | INTERVENTIONAL | unchanged | 2,541.85 | 0 |
|---|
| The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study | 09/12/2019 | OBSERVATIONAL | unchanged | 2,540.85 | 0 |
|---|
| Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors | 09/13/2019 | INTERVENTIONAL | unchanged | 2,539.85 | 0 |
|---|
| Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer | 09/16/2019 | INTERVENTIONAL | unchanged | 2,536.85 | 0 |
|---|
| Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum | 09/16/2019 | INTERVENTIONAL | unchanged | 2,536.85 | 0 |
|---|
| Improving Preschool Outcomes by Addressing Maternal Depression in Head Start | 09/17/2019 | INTERVENTIONAL | unchanged | 2,535.85 | 0 |
|---|
| A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer | 09/17/2019 | INTERVENTIONAL | unchanged | 2,535.85 | 0 |
|---|
| Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama | 09/18/2019 | INTERVENTIONAL | unchanged | 2,534.85 | 0 |
|---|
| Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy | 09/19/2019 | INTERVENTIONAL | unchanged | 2,533.85 | 0 |
|---|
| Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | 09/19/2019 | INTERVENTIONAL | unchanged | 2,533.85 | 0 |
|---|
| Alternative Prophylaxis in Female Recurrent Urinary Tract Infections | 09/19/2019 | INTERVENTIONAL | unchanged | 2,533.85 | 0 |
|---|
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) | 09/23/2019 | INTERVENTIONAL | unchanged | 2,529.85 | 0 |
|---|
| Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST | 09/24/2019 | INTERVENTIONAL | unchanged | 2,528.85 | 0 |
|---|
| Advancing Postmenopausal Preventive Therapy | 09/25/2019 | INTERVENTIONAL | unchanged | 2,527.85 | 0 |
|---|
| Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment | 09/27/2019 | INTERVENTIONAL | unchanged | 2,525.85 | 0 |
|---|
| Pilot Study for Speculum Free Cervical Cancer Screening | 09/27/2019 | INTERVENTIONAL | unchanged | 2,525.85 | 0 |
|---|
| Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa | 09/27/2019 | INTERVENTIONAL | unchanged | 2,525.85 | 0 |
|---|
| Obstetric Placement Study Using EST | 09/30/2019 | INTERVENTIONAL | unchanged | 2,522.85 | 0 |
|---|
| Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos | 09/30/2019 | INTERVENTIONAL | unchanged | 2,522.85 | 0 |
|---|
| Personalizing Osteoporosis Care: Clinical & Genetic Risk Factors for AFFs | 10/01/2019 | OBSERVATIONAL | unchanged | 2,521.85 | 0 |
|---|
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | 10/02/2019 | INTERVENTIONAL | unchanged | 2,520.85 | 0 |
|---|
| Mitochondrial Donation: An 18 Month Outcome Study. | 10/02/2019 | OBSERVATIONAL | unchanged | 2,520.85 | 0 |
|---|
| Bazedoxifene -Treatment for Women With Schizophrenia | 10/03/2019 | INTERVENTIONAL | unchanged | 2,519.85 | 0 |
|---|
| Trial of Flexible Bracing Treatment of Adolescents Idiopathic Scoliosis | 10/07/2019 | INTERVENTIONAL | unchanged | 2,515.85 | 0 |
|---|
| NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer | 10/08/2019 | OBSERVATIONAL | unchanged | 2,514.85 | 0 |
|---|
| Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age | 10/08/2019 | OBSERVATIONAL | unchanged | 2,514.85 | 0 |
|---|
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | 10/11/2019 | INTERVENTIONAL | unchanged | 2,511.85 | 0 |
|---|
| The SONImage Study | 10/14/2019 | INTERVENTIONAL | unchanged | 2,508.85 | 0 |
|---|
| Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer | 10/15/2019 | INTERVENTIONAL | unchanged | 2,507.85 | 0 |
|---|
| Effect of Addition of Steroids on Duration of Analgesia | 10/15/2019 | INTERVENTIONAL | unchanged | 2,507.85 | 0 |
|---|
| In Vitro Fertilisation Versus Intracytoplasmic Sperm Injection in Patients Without Severe Male Factor Infertility | 10/16/2019 | INTERVENTIONAL | unchanged | 2,506.85 | 0 |
|---|
| Intraperitoneal Infusion of Analgesic for Postoperative Pain Management | 10/17/2019 | INTERVENTIONAL | unchanged | 2,505.85 | 0 |
|---|
| HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia | 10/18/2019 | INTERVENTIONAL | unchanged | 2,504.85 | 0 |
|---|
| Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer | 10/21/2019 | INTERVENTIONAL | unchanged | 2,501.85 | 0 |
|---|
| ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer | 10/22/2019 | INTERVENTIONAL | unchanged | 2,500.85 | 0 |
|---|
| Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer | 10/22/2019 | INTERVENTIONAL | unchanged | 2,500.85 | 0 |
|---|
| Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | 10/23/2019 | INTERVENTIONAL | unchanged | 2,499.85 | 0 |
|---|
| Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT | 10/24/2019 | INTERVENTIONAL | unchanged | 2,498.85 | 0 |
|---|
| Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer | 10/24/2019 | INTERVENTIONAL | unchanged | 2,498.85 | 0 |
|---|
| Autonomic Determinants of POTS - Pilot 2 | 10/28/2019 | INTERVENTIONAL | unchanged | 2,494.85 | 0 |
|---|
| LUMIERE on the FETUS | 10/29/2019 | OBSERVATIONAL | unchanged | 2,493.85 | 0 |
|---|
| A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception | 10/29/2019 | INTERVENTIONAL | unchanged | 2,493.85 | 0 |
|---|
| A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | 10/30/2019 | INTERVENTIONAL | unchanged | 2,492.85 | 0 |
|---|
| Von Willebrand Factor in Pregnancy (VIP) Study | 10/31/2019 | OBSERVATIONAL | unchanged | 2,491.85 | 0 |
|---|
| IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer | 11/04/2019 | INTERVENTIONAL | unchanged | 2,487.85 | 0 |
|---|
| Conservative Endometrioma Surgery | 11/05/2019 | INTERVENTIONAL | unchanged | 2,486.85 | 0 |
|---|
| Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer | 11/05/2019 | OBSERVATIONAL | unchanged | 2,486.85 | 0 |
|---|
| Exosome Cargo From Preeclampsia Patients | 11/06/2019 | OBSERVATIONAL | unchanged | 2,485.85 | 0 |
|---|
| Optical Biopsy in Gynecological Surgery | 11/06/2019 | INTERVENTIONAL | unchanged | 2,485.85 | 0 |
|---|
| Creation and Validation of a Questionnaire Evaluating Diastasis Recti | 11/08/2019 | OBSERVATIONAL | unchanged | 2,483.85 | 0 |
|---|
| Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer | 11/08/2019 | INTERVENTIONAL | unchanged | 2,483.85 | 0 |
|---|
| Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis | 11/12/2019 | INTERVENTIONAL | unchanged | 2,479.85 | 0 |
|---|
| Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer | 11/12/2019 | INTERVENTIONAL | unchanged | 2,479.85 | 0 |
|---|
| Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy | 11/13/2019 | INTERVENTIONAL | unchanged | 2,478.85 | 0 |
|---|
| Trigger Timing in Ovarian Stimulations | 11/14/2019 | INTERVENTIONAL | unchanged | 2,477.85 | 0 |
|---|
| Ovarian Hyperstimulation and Fibrin Clot Properties. | 11/18/2019 | INTERVENTIONAL | unchanged | 2,473.85 | 0 |
|---|
| Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP) | 11/18/2019 | INTERVENTIONAL | unchanged | 2,473.85 | 0 |
|---|
| Preimplantation Genetic Testing in Women of Advanced Maternal Age | 11/19/2019 | INTERVENTIONAL | unchanged | 2,472.85 | 0 |
|---|
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery | 11/20/2019 | OBSERVATIONAL | unchanged | 2,471.85 | 0 |
|---|
| A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer | 11/20/2019 | INTERVENTIONAL | unchanged | 2,471.85 | 0 |
|---|
| Lifestyles and Breast Cancer | 11/22/2019 | INTERVENTIONAL | unchanged | 2,469.85 | 0 |
|---|
| Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer | 11/22/2019 | OBSERVATIONAL | unchanged | 2,469.85 | 0 |
|---|
| Prospective Randomized Study of Accelerated Radiation Therapy (PRART) | 11/22/2019 | INTERVENTIONAL | unchanged | 2,469.85 | 0 |
|---|
| CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer | 11/25/2019 | INTERVENTIONAL | unchanged | 2,466.85 | 0 |
|---|
| Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation | 11/26/2019 | INTERVENTIONAL | unchanged | 2,465.85 | 0 |
|---|
| Vitamin D and Health Status of British African-Caribbean Women | 11/27/2019 | OBSERVATIONAL | unchanged | 2,464.85 | 0 |
|---|
| Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse | 11/27/2019 | OBSERVATIONAL | unchanged | 2,464.85 | 0 |
|---|
| Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients | 11/27/2019 | INTERVENTIONAL | unchanged | 2,464.85 | 0 |
|---|
| Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes. | 12/03/2019 | OBSERVATIONAL | unchanged | 2,458.85 | 0 |
|---|
| Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2 | 12/05/2019 | OBSERVATIONAL | unchanged | 2,456.85 | 0 |
|---|
| Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) | 12/10/2019 | INTERVENTIONAL | unchanged | 2,451.85 | 0 |
|---|
| Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer | 12/10/2019 | INTERVENTIONAL | unchanged | 2,451.85 | 0 |
|---|
| Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study | 12/11/2019 | OBSERVATIONAL | unchanged | 2,450.85 | 0 |
|---|
| Breastfeeding and Gut Health | 12/11/2019 | OBSERVATIONAL | unchanged | 2,450.85 | 0 |
|---|
| Study of the Impact of DPD Activity on the Efficacy of Capecitabine | 12/13/2019 | INTERVENTIONAL | unchanged | 2,448.85 | 0 |
|---|
| Immediate Postpartum Glucose Tolerance Testing | 12/16/2019 | OBSERVATIONAL | unchanged | 2,445.85 | 0 |
|---|
| Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy | 12/19/2019 | INTERVENTIONAL | unchanged | 2,442.85 | 0 |
|---|
| Sleep Behaviors in Pregnancy | 12/19/2019 | INTERVENTIONAL | unchanged | 2,442.85 | 0 |
|---|
| iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes | 12/20/2019 | INTERVENTIONAL | unchanged | 2,441.85 | 0 |
|---|
| An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen | 12/20/2019 | INTERVENTIONAL | unchanged | 2,441.85 | 0 |
|---|
| Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study | 12/23/2019 | INTERVENTIONAL | unchanged | 2,438.85 | 0 |
|---|
| Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis | 12/23/2019 | INTERVENTIONAL | unchanged | 2,438.85 | 0 |
|---|
| Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model | 12/30/2019 | OBSERVATIONAL | unchanged | 2,431.85 | 0 |
|---|
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer | 12/30/2019 | INTERVENTIONAL | unchanged | 2,431.85 | 0 |
|---|